Biotechnology in the United States industry profile provides top-line qualitative and quantitative summary information including: market size (value 2006-10, and forecast to 2015). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the United States biotechnology market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Highlights

The biotechnology market consists of the development, manufacturing and marketing of products based on advanced biotechnology research. The market value reflects revenues of companies within this industry from product sales, licensing fees, royalties and research funding. Any currency conversions used in the creation of this report have been calculated using constant 2011 annual average exchange rates.
The US biotechnology market had total revenue of $84,821 million in 2010, representing a compound annual growth rate (CAGR) of 9.8% between 2006 and 2010.
Medical/Healthcare sales proved the most lucrative for the US biotechnology market in 2010, with total revenues of $57,044.1 million, equivalent to 67.3% of the market's overall value.
The performance of the market is forecast to decelerate, with an anticipated CAGR of 0.3% for the five-year period 2010 - 2015, which is expected to drive the market to a value of $86,245.9 million by the end of 2015.

Features

Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in the United States

Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in the United States

Leading company profiles reveal details of key biotechnology market players' global operations and financial performance

Add weight to presentations and pitches by understanding the future growth prospects of the United States biotechnology market with five year forecasts

Macroeconomic indicators provide insight into general trends within the United States economy

Key Questions Answered

What was the size of the United States biotechnology market by value in 2010?

What will be the size of the United States biotechnology market in 2015?

What factors are affecting the strength of competition in the United States biotechnology market?

How has the market performed over the last five years?

What are the main segments that make up the United States's biotechnology market?

EXECUTIVE SUMMARY
MARKET OVERVIEW
- Market definition
- Research highlights
- Market analysis
MARKET VALUE
MARKET SEGMENTATION I
MARKET SEGMENTATION II
FIVE FORCES ANALYSIS
- Summary
- Buyer power
- Supplier power
- New entrants
- Substitutes
- Rivalry
LEADING COMPANIES
- Amgen
- Genentech Inc
- Merck KGaA
- Pfizer Inc
MARKET FORECASTS
- Market value forecast
MACROECONOMIC INDICATORS
APPENDIX
- Methodology
- Industry associations
- Related Datamonitor research
- Disclaimer
ABOUT DATAMONITOR
- Premium Reports
- Summary Reports
- Datamonitor consulting
LIST OF TABLES
- Table 1: United States biotechnology market value: $ million, 2006-10
- Table 2: United States biotechnology market segmentation I:% share, by value, 2010
- Table 3: United States biotechnology market segmentation II: % share, by value, 2010
- Table 4: Amgen: key facts
- Table 5: Amgen: key financials ($)
- Table 6: Amgen: key financial ratios
- Table 7: Genentech Inc: key facts
- Table 8: Genentech Inc: key financials ($)
- Table 9: Genentech Inc: key financials (CHF)
- Table 10: Genentech Inc: key financial ratios
- Table 11: Merck KGaA: key facts
- Table 12: Merck KGaA: key financials ($)
- Table 13: Merck KGaA: key financials (€)
- Table 14: Merck KGaA: key financial ratios
- Table 15: Pfizer Inc: key facts
- Table 16: Pfizer Inc: key financials ($)
- Table 17: Pfizer Inc: key financial ratios
- Table 18: United States biotechnology market value forecast: $ million, 2010-15
- Table 19: United States size of population (million), 2006-10
- Table 20: United States gdp (constant 2000 prices, $ billion), 2006-10
- Table 21: United States gdp (current prices, $ billion), 2006-10
- Table 22: United States inflation, 2006-10
- Table 23: United States consumer price index (absolute), 2006-10
- Table 24: United States exchange rate, 2006-10
LIST OF FIGURES
- Figure 1: United States biotechnology market value: $ million, 2006-10
- Figure 2: United States biotechnology market segmentation I:% share, by value, 2010
- Figure 3: United States biotechnology market segmentation II: % share, by value, 2010
- Figure 4: Forces driving competition in the biotechnology market in the United States, 2010
- Figure 5: Drivers of buyer power in the biotechnology market in the United States, 2010
- Figure 6: Drivers of supplier power in the biotechnology market in the United States, 2010
- Figure 7: Factors influencing the likelihood of new entrants in the biotechnology market in the United States, 2010
- Figure 8: Factors influencing the threat of substitutes in the biotechnology market in the United States, 2010
- Figure 9: Drivers of degree of rivalry in the biotechnology market in the United States, 2010
- Figure 10: Amgen: revenues & profitability
- Figure 11: Amgen: assets & liabilities
- Figure 12: Genentech Inc: revenues & profitability
- Figure 13: Genentech Inc: assets & liabilities
- Figure 14: Merck KGaA: revenues & profitability
- Figure 15: Merck KGaA: assets & liabilities
- Figure 16: Pfizer Inc: revenues & profitability
- Figure 17: Pfizer Inc: assets & liabilities
- Figure 18: United States biotechnology market value forecast: $ million, 2010-15

Pharmaceutical Market Research

Biotechnology in the United States